• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

Custom Skincare Development Handover: Which Formula Files Should a Gulf Brand Retain?

A Gulf skincare launch rarely fails because the formula was weak. It fails at handover: the brand receives a good sample and an INCI list, then discovers months later that no one can reproduce…

Category: Skincare Sourcing Guides • Author: laeyo • Published: 2026-11-12 • Views: 31

A Gulf skincare launch rarely fails because the formula was weak. It fails at handover: the brand receives a good sample and an INCI list, then discovers months later that no one can reproduce the batch, the stability file belongs to an older version, or the airless pump was never tested with the real emulsion at 45 °C. This guide sets out exactly which formula files a Gulf brand should retain, what evidence proves each one is genuine, and how to confirm the handover is complete before the final invoice is paid.

Why Gulf handovers are harder than they look

Three pressures converge in Gulf markets and make documentation gaps expensive:

  • Climate stress. Warehouse and delivery temperatures routinely exceed what a European lab tested at 25 °C. A formula that is stable in a mild climate can separate, thin, or discolor in a Dubai summer.
  • Registration before revenue. Product registration (for example Dubai Municipality Montaji in the UAE, or SFDA in Saudi Arabia) requires a dossier that must match the formula and label exactly. A mismatched version stops the launch.
  • Label and claim scrutiny. Arabic label copy, fragrance allergen declarations, and skin-brightening claims all attract review. Claims that cannot be substantiated are usually removed at the border, not in the marketing meeting.

The practical consequence: the brand must own a record, not just a product. You do not need the factory’s entire process library. You do need a controlled document set that lets a competent third party reproduce the batch, defend the claims, and answer a regulator.

TL;DR — the 60-second version

  • What triggers the risk: heat and humidity, mandatory registration dossiers, Arabic labeling, and any claim that sounds like lightening, anti-acne, or SPF. Each one increases the documentation you must be able to produce.
  • Decide these three things first: (1) which exact Formula ID and version you are buying; (2) whether the pack is a stock, semi-custom, or custom mold route; (3) which markets you will register in during the first 12 months.
  • Fastest safe path: lock the formula version and the pack part numbers before artwork, run accelerated stability and packaging compatibility in parallel, and pilot before final label print. Reject any request to compress stability or compatibility testing.
  • Evidence to request immediately: master formula with ranges, version change log, stability raw data at 40 °C/75% RH, challenge test (ISO 11930) naming the same Formula ID, and the packaging compatibility report with dose-weight data.
  • Ownership in writing: a signed clause that names the formula, the exclusivity scope, the markets, the duration, and the tooling. Verbal exclusivity is not an asset.

Informational only, not legal advice. Registration responsibility and dossier requirements vary by emirate and by country; confirm with your local responsible person or regulatory consultant.

Decision tree: how much documentation do you actually need

  • Start here. Selling one hero SKU into one Gulf market on a stock chassis and stock pack? → Retain the core pack: formula ID, master formula, stability, micro, compatibility, label, safety assessment.
  • Registering in two or more GCC markets? → Add per-market dossier copies, submission receipts, and free sale certificates.
  • Making a brightening, anti-acne, or SPF-type claim? → Stop. Get a written regulatory opinion on the active and the claim wording before formula lock, then retain the full substantiation file with raw data.
  • Using a custom mold or a new pump/airless system? → Add tooling drawings, part numbers, resin and gasket material specs, tool ownership, and a full compatibility study in the production pack.
  • Planning to move to a second factory within 24 months? → Add the process instruction set and run a reproducibility trial before you accept the handover.
  • Brand is halal-positioned or exports to Saudi Arabia? → Add halal certificates and animal-derived origin declarations per raw material, not per product.
  • Boundary case: if the manufacturer will not disclose the master formula under any commercial structure, treat it as a supply relationship, not an owned asset, and price your risk accordingly.
  • Boundary case: if any document references a different Formula ID, batch, or pack than the one you are launching, the handover is incomplete regardless of what the invoice says.

The minimum handover pack: what to ask your manufacturer

A) Compliance, filings, and registration

  • Request: the registration dossier package for each target market, plus submission receipts.
    Evidence: full dossier copy, responsible-person appointment, authority acknowledgements.
    Owner: Manufacturer (inputs) and Buyer (filing party).
    Acceptance criteria: you hold a complete copy, and no open deficiency letter references a document you do not have.
  • Request: a safety assessment naming the exact Formula ID and version.
    Evidence: signed report with toxicological justification and the assessor’s credentials.
    Owner: Lab or qualified safety assessor.
    Acceptance criteria: the Formula ID and date on the report match your retained master formula.
  • Request: a signed declaration on restricted and prohibited substances, including skin-lightening actives.
    Evidence: countersigned declaration plus supporting raw material CoAs.
    Owner: Manufacturer.
    Acceptance criteria: every ingredient is declared with a concentration, and nothing exceeds the applicable limit.
  • Request: halal and animal-derived origin statements, and GMP certificate (ISO 22716).
    Evidence: certificates that name the actual manufacturing site and the specific raw material grades.
    Owner: Manufacturer and raw material suppliers.
    Acceptance criteria: certificates are in date and cover the site and grade actually used, not a group-level certificate.

B) Formula identity and version control

  • Request: the master formula per 100 kg, with % w/w, allowed ranges, phase order, and process temperatures.
    Evidence: controlled document with Formula ID, revision number, and approval signatures.
    Owner: Manufacturer.
    Acceptance criteria: totals 100% within ±0.5%, includes ranges rather than single values, and lists every phase.
  • Request: the version history and change log.
    Evidence: a table with Formula ID, change reason, affected raw materials (old and new INCI plus supplier and lot), impact assessment, test scope, and approvals.
    Owner: Manufacturer.
    Acceptance criteria: no version is labelled with vague names such as “final final v2”; every change has a stated reason and an approval.
  • Request: the full INCI, CAS, and concentration file with supplier names and grades.
    Evidence: ingredient declaration sheet cross-referenced to raw material CoAs.
    Owner: Manufacturer and raw material suppliers.
    Acceptance criteria: matches the master formula and the printed label one-to-one, including fragrance allergen declaration.
  • Request: process instructions detailed enough for a second operator.
    Evidence: mixing speed and time, homogenization, pH adjustment, cooling ramp, fill temperature, filtration, and hold times.
    Owner: Manufacturer.
    Acceptance criteria: a second site can run a bench trial and land within the stated tolerances.

C) Testing and substantiation

  • Request: the stability protocol and the raw data, not a one-page summary.
    Evidence: accelerated data at 40 °C/75% RH, freeze-thaw cycles, temperature cycling, photostability where relevant, plus real-time data or a committed schedule.
    Owner: Manufacturer or contract lab.
    Acceptance criteria: each timepoint records pH, viscosity, appearance, odor, color, and photographs, against the same Formula ID and pack.
  • Request: the preservative efficacy (challenge) test and routine micro specifications.
    Evidence: ISO 11930 report run on pilot-scale product in the final pack, plus total plate count and specified organisms with limits.
    Owner: Lab.
    Acceptance criteria: passes with margin, not borderline, and the report references the exact Formula ID.
  • Request: claim substantiation for every on-pack claim.
    Evidence: test protocol, raw data, statistics, panel size, and the approved claim wording that the data supports.
    Owner: Lab and Buyer (claim approval).
    Acceptance criteria: every claim maps to a specific study, and no claim exceeds what the data shows.
  • Request: the packaging compatibility report.
    Evidence: 8–12 weeks at 40 °C with the real formula in the real pack, plus drop, leak, vacuum, and dose-weight consistency data at start and end of test.
    Owner: Manufacturer and packaging supplier.
    Acceptance criteria: no swelling, discoloration, leakage, or dose drift beyond the agreed tolerance.

D) QA, traceability, and audit readiness

  • Request: the batch record template, the pilot batch record, and the deviation log.
    Evidence: signed records with in-process checks and any deviations plus disposition.
    Owner: Manufacturer.
    Acceptance criteria: every in-process value has a specification and an actual result.
  • Request: the Golden Sample set with photographs and a color standard.
    Evidence: retained sample per batch, reference photos under fixed lighting, and color values.
    Owner: Manufacturer and Buyer.
    Acceptance criteria: the retained sample is signed by both parties and stored under defined conditions.
  • Request: a written ownership and exclusivity clause.
    Evidence: signed agreement naming the formula, markets, duration, purchase commitments, and tooling ownership.
    Owner: Buyer and Manufacturer.
    Acceptance criteria: the clause is specific enough that a third party could enforce it without interpretation.

Evidence pack summary

  • Master formula per 100 kg with ranges and process parameters.
  • Formula ID register with version history and change log.
  • INCI, CAS, concentration file cross-referenced to raw material lots.
  • Raw material specifications, last three CoAs, and GHS-format SDS.
  • Stability protocol and raw data at 40 °C/75% RH plus freeze-thaw.
  • Challenge test report (ISO 11930) and routine micro specifications.
  • Packaging compatibility report with dose-weight data.
  • Claim substantiation files and approved label copy in Arabic and English.
  • Safety assessment naming the same Formula ID.
  • Registration dossier copies and submission receipts per market.
  • Halal and animal-derived origin declarations per raw material.
  • Pilot batch record, deviation log, and signed Golden Sample.

Timeline: a realistic end-to-end plan

Durations below assume the pack is available and the formula base is already qualified. Add 4–8 weeks for a custom mold and 2–6 weeks for authority review, depending on the market.

Phase Buyer action Manufacturer action Evidence output Fastest safe path Standard path
1. File-gap audit List target markets and claims; request the evidence pack Map documents to the requested Formula ID Gap list with owners and deadlines 1 week 2–3 weeks
2. Formula and pack lock Approve Formula ID and pack part numbers in writing Freeze the version; confirm pack resin and gasket materials Signed formula freeze sheet and pack specification 1–2 weeks 3–4 weeks
3. Stability, micro, compatibility Approve protocols before testing starts Run accelerated, freeze-thaw, challenge test, compatibility Raw data reports per test 8–12 weeks in parallel 12–16 weeks plus real-time
4. Label and claims review Approve Arabic and English copy against the master formula Supply INCI, allergens, and claim support Approved artwork file plus claim-to-study map 2–3 weeks 4–6 weeks
5. Registration submission File with the responsible person or consultant Provide dossier inputs and clarifications Submission receipt and approval Parallel with phase 3 After phase 3 completes
6. Pilot run Attend or review the pilot report Produce pilot batch, record in-process values Pilot batch record and deviation log 2 weeks 3–4 weeks
7. Documentation handover Run a reproducibility check against the retained sample Release the full evidence pack Signed handover list and archive index 1 week 2 weeks

What can be compressed: artwork rounds, pilot scheduling, registration submission timing (run it in parallel), and internal review cycles.

What cannot be compressed: accelerated stability duration, challenge test duration, packaging compatibility time, real-time stability commitments, and label-to-formula reconciliation.

Common failure modes: how Gulf projects get delayed or rejected

1. Packaging compatibility failure in an airless or pump system

  • Symptom: dose weight drops, the pump stiffens, or the product discolors near the neck after 6–8 weeks in market.
  • Root cause: the elastomer or valve material was never tested with the actual emulsion at Gulf ambient; fragrance or solvent swells the gasket, or the viscosity is outside the pump’s operating window.
  • Prevention: run compatibility with the real formula at production viscosity in the production pack, at 40 °C plus a 45 °C excursion, and measure dose weight at the start and end of the test.
  • What to request from factory (Evidence): signed compatibility report listing pack supplier part numbers and gasket material, with dose-weight data and timepoint photographs.

2. Documentation failure: INCI does not match the dossier

  • Symptom: registration query or customs hold because the label INCI differs from the filed formula.
  • Root cause: artwork was built from an earlier version, or a raw material grade changed without a change note.
  • Prevention: freeze the Formula ID before artwork begins; keep one controlled source of truth; have QA, not marketing, sign the label against the master formula.
  • What to request from factory (Evidence): a side-by-side INCI comparison sheet signed by QA, the version-controlled artwork file, and the change log.

3. Viscosity drift at scale-up

  • Symptom: the pilot batch is thinner or thicker, fill weights are off, and the pump under-doses.
  • Root cause: lab homogenizer versus production equipment, different cooling ramp, order of thickener addition, or raw material lot variation.
  • Prevention: specify viscosity with spindle, speed, and temperature; define the process window; run a pilot before artwork approval.
  • What to request from factory (Evidence): pilot batch record with the in-process viscosity curve and the agreed specification range.

4. Emulsion separation after heat exposure

  • Symptom: separation or graininess after 4–8 weeks in a hot warehouse or delivery van.
  • Root cause: only ambient data was generated, or the stability study used a different version or pack.
  • Prevention: require 40 °C/75% RH data, temperature cycling, and ship-mode simulation alongside real-time data.
  • What to request from factory (Evidence): the full stability report with batch numbers and the Formula ID on every page.

5. Micro failure six months after launch

  • Symptom: the challenge test passed in the lab, but market samples show mold or a count excursion.
  • Root cause: a borderline preservative system, preservative absorbed by the pack, pH drift, or a high fragrance load.
  • Prevention: run the challenge test on pilot-scale product in the final pack; check preservative recovery from the pack; keep a margin, not a pass.
  • What to request from factory (Evidence): ISO 11930 report tied to the Formula ID and pack, plus preservative assay data at release.

6. Claim rejection on brightening or treatment wording

  • Symptom: the registration is returned with a claim or ingredient objection.
  • Root cause: a restricted active, or wording that the evidence does not support.
  • Prevention: get a written regulatory opinion on the active and the claim before formula lock; rewrite claims to what the data shows.
  • What to request from factory (Evidence): claim substantiation file, regulatory opinion, and approved Arabic label copy.

7. Fragrance-driven discoloration and missing allergen declaration

  • Symptom: the cream yellows within weeks, or the allergen declaration is absent from the label.
  • Root cause: the fragrance was selected on a smelling strip and never tested in the base; allergen data was never obtained.
  • Prevention: test the fragrance in the real base and pack at 40 °C; obtain the allergen declaration and usage certificate at selection.
  • What to request from factory (Evidence): fragrance supplier declaration, usage and IFRA documentation where applicable, and base compatibility data with photographs.

8. Ownership dispute after the first purchase order

  • Symptom: the brand is asked to pay again for the formula, or cannot move production to a second site.
  • Root cause: no written assignment; the formula was treated as the manufacturer’s background IP.
  • Prevention: sign a clause naming the Formula ID, exclusivity scope, markets, duration, purchase commitments, and tooling ownership before development starts.
  • What to request from factory (Evidence): the signed development agreement with an asset schedule listing every document in the pack.

Red lines: what never gets cut to save budget

  • Do not launch on accelerated stability shorter than 3 months at 40 °C/75% RH plus freeze-thaw cycles.
  • Do not accept a challenge test run on a lab sample in a glass jar when you are selling an airless or pump pack.
  • Do not print labels before the Formula ID is frozen and QA has signed the INCI reconciliation.
  • Do not run a packaging compatibility study with water or a placebo instead of the real formula.
  • Do not accept a safety assessment that does not name your Formula ID and version.
  • Do not put a functional claim on pack without a protocol, raw data, and statistics behind it.
  • Do not skip the pilot batch, even when the lab sample was perfect.
  • Do not accept verbal exclusivity. Ever.

Copy-paste checklist for your supplier email

Share target markets: UAE, Saudi Arabia, and any other GCC state you will register in.
Confirm the exact Formula ID and version we are purchasing.
Provide the master formula per 100 kg with % w/w, ranges, and phase order.
Provide the full INCI, CAS, and concentration file with supplier names and grades.
Attach the version change log with reasons, affected materials, and impact assessments.
Provide raw material specifications, the last three CoAs, and GHS-format SDS.
Provide the stability protocol and raw data, not a summary page.
Confirm 40 C/75% RH data, freeze-thaw cycles, and the real-time schedule.
Provide the challenge test report referencing our Formula ID and the final pack.
Provide the packaging compatibility report including dose-weight data.
Lock the pack: part numbers, resin, gasket material, and decoration specifications.
Approve the viscosity specification with spindle, speed, and temperature stated.
Review Arabic and English label copy against the master formula before print.
Provide claim substantiation files for every on-pack claim.
Provide the safety assessment naming the same Formula ID and date.
Provide registration dossier copies and submission receipts per market.
Confirm halal and animal-derived origin declarations per raw material.
Provide the pilot batch record, deviation log, and retain sample photographs.
Confirm formula ownership, exclusivity scope, and tooling ownership in writing.
Test reproducibility: a second site must match pH, viscosity, and color tolerances.
Approve the final documentation handover list and archive it with the Golden Sample.

Summary table: the ten decisions that determine your handover

Lever / Decision Primary impact What to do (specific) Do NOT cut (red line) Evidence needed (request) Expected timeline effect
Formula identity and version freeze Prevents every downstream mismatch Assign one Formula ID per version and freeze it before artwork No vague version names; every change logged with reason and approval Formula ID register and change log Saves 2–4 weeks of rework
Master formula disclosure Determines whether you own an asset or rent a supply Negotiate disclosure at the commercial stage, not after the first order Formula must total 100% ±0.5% with ranges and phase order Controlled master formula with approval signatures Adds 1–2 weeks of negotiation, prevents redevelopment cost
Stability package Protects against heat-driven returns in the Gulf Run 3 months at 40 °C/75% RH plus freeze-thaw, and commit to real-time No launch on ambient-only data Stability protocol and raw data with timepoint photographs 8–12 weeks, run in parallel with compatibility
Preservative and micro strategy Prevents recall and reputation damage Challenge test pilot-scale product inside the final pack Pass with margin, not borderline, on the exact Formula ID ISO 11930 report plus routine micro specifications 6–8 weeks; re-testing adds 6 weeks
Packaging compatibility Stops leaks, dose drift, and discoloration Test the real formula at production viscosity in the real pack at 40 °C No placebo or water-filled compatibility studies Compatibility report with dose-weight data and part numbers 8–12 weeks; failures add a full pack re-selection cycle
Label and claims control Determines whether the product clears registration QA-sign the INCI reconciliation and map every claim to a study No unsubstantiated brightening, anti-acne, or SPF-type wording Approved artwork file and claim-to-study map 2–6 weeks; one rejection typically adds 4 weeks
Registration timing Controls the actual launch date Submit in parallel with stability once the dossier is complete No submission with a placeholder or missing safety assessment Dossier copies and submission receipts 2–6 weeks of authority review, market dependent
Halal and origin declarations Blocks or enables Saudi and halal-positioned listings Collect per raw material at selection, not per finished product Certificates must name the site and the grade actually used Halal certificates and animal-derived origin statements Adds 2–6 weeks if collected late
Pilot batch and scale-up Exposes process-driven defects before mass production Run a pilot before final label print and compare against the Golden Sample No skipping the pilot, even after a perfect lab sample Pilot batch record, deviation log, retain sample photos 2–4 weeks; skipping it risks a full batch loss
Ownership and exclusivity Protects the asset and your ability to switch suppliers Sign a clause naming formula, markets, duration, volumes, and tooling No verbal exclusivity and no undefined scope Signed development agreement with an asset schedule 1–2 weeks of legal review, avoids a full redevelopment

FAQ

Do I need the full formula, or is the INCI list enough?

An INCI list is a labeling output, not a manufacturing document. It cannot reproduce a batch, and it does not define process, pH, viscosity, or preservative strategy. If you intend to own the product long term, negotiate the master formula with ranges and process parameters; if the manufacturer refuses, treat it as a supply agreement and plan for dependency.

Can I use the manufacturer’s safety assessment for Gulf registration?

Usually the manufacturer supplies inputs while the safety assessment, product information file, and notification are handled by a qualified assessor or your local responsible party. What matters is that the assessment names the exact Formula ID and version you are launching, and that your filing party confirms it meets the specific market’s requirements.

How long should we keep retain samples and records?

Follow the market requirement and your own quality system, and in practice keep records and a retained sample for at least the product shelf life plus a margin. Store retained samples under defined conditions and log them, because a retain sample without storage records proves very little.

How do I know the handover is actually complete?

Run a reproducibility check: have a second site or a separate bench produce a small batch from the documents alone. If pH, viscosity, appearance, and color land inside the agreed tolerances and the challenge test logic still holds, the pack is complete. If the second batch needs a phone call to the original chemist, it is not.

Is halal certification mandatory for skincare in the Gulf?

It depends on the market, the channel, and your positioning. It is frequently a commercial requirement rather than a universal legal one. The practical step is to collect halal and animal-derived origin declarations per raw material early, so the option stays open without delaying launch.

Next step

If you are preparing a Gulf skincare launch and want the evidence pack scoped against your actual formula and pack, send us the details and we will map the documentation gaps before you commit to tooling or artwork.

To get a faster quote, include: target markets, SKU count and formats, brand positioning, packaging direction (stock, semi-custom, or custom mold), and your target launch date.

Request a Quote

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).